Belite Bio (BLTE) Tops Q4 EPS by 15c
Belite Bio (NASDAQ: BLTE) reported Q4 EPS of ($0.38), $0.15 better than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Belite Bio (BLTE) click here.
Belite Bio (NASDAQ: BLTE) reported Q4 EPS of ($0.38), $0.15 better than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Belite Bio (BLTE) click here.